nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—Localized exfoliation—Triamcinolone—ankylosing spondylitis	0.066	0.066	CcSEcCtD
Vildagliptin—Blister—Prednisolone—ankylosing spondylitis	0.0268	0.0268	CcSEcCtD
Vildagliptin—Blister—Triamcinolone—ankylosing spondylitis	0.0247	0.0247	CcSEcCtD
Vildagliptin—Blister—Dexamethasone—ankylosing spondylitis	0.0224	0.0224	CcSEcCtD
Vildagliptin—Blister—Betamethasone—ankylosing spondylitis	0.0224	0.0224	CcSEcCtD
Vildagliptin—Skin exfoliation—Triamcinolone—ankylosing spondylitis	0.017	0.017	CcSEcCtD
Vildagliptin—Skin exfoliation—Methylprednisolone—ankylosing spondylitis	0.0169	0.0169	CcSEcCtD
Vildagliptin—Skin exfoliation—Betamethasone—ankylosing spondylitis	0.0154	0.0154	CcSEcCtD
Vildagliptin—Skin exfoliation—Dexamethasone—ankylosing spondylitis	0.0154	0.0154	CcSEcCtD
Vildagliptin—Dermatitis bullous—Prednisolone—ankylosing spondylitis	0.0147	0.0147	CcSEcCtD
Vildagliptin—Dermatitis bullous—Triamcinolone—ankylosing spondylitis	0.0135	0.0135	CcSEcCtD
Vildagliptin—Skin exfoliation—Prednisone—ankylosing spondylitis	0.0134	0.0134	CcSEcCtD
Vildagliptin—Dermatitis bullous—Dexamethasone—ankylosing spondylitis	0.0123	0.0123	CcSEcCtD
Vildagliptin—Dermatitis bullous—Betamethasone—ankylosing spondylitis	0.0123	0.0123	CcSEcCtD
Vildagliptin—Pancreatitis—Prednisolone—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Vildagliptin—Skin exfoliation—Methotrexate—ankylosing spondylitis	0.0112	0.0112	CcSEcCtD
Vildagliptin—Weight increased—Prednisolone—ankylosing spondylitis	0.011	0.011	CcSEcCtD
Vildagliptin—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Vildagliptin—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.0104	0.0104	CcSEcCtD
Vildagliptin—Weight increased—Triamcinolone—ankylosing spondylitis	0.0102	0.0102	CcSEcCtD
Vildagliptin—Weight increased—Methylprednisolone—ankylosing spondylitis	0.0101	0.0101	CcSEcCtD
Vildagliptin—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00993	0.00993	CcSEcCtD
Vildagliptin—Infestation—Methylprednisolone—ankylosing spondylitis	0.00993	0.00993	CcSEcCtD
Vildagliptin—Weight increased—Dexamethasone—ankylosing spondylitis	0.00921	0.00921	CcSEcCtD
Vildagliptin—Weight increased—Betamethasone—ankylosing spondylitis	0.00921	0.00921	CcSEcCtD
Vildagliptin—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00876	0.00876	CcSEcCtD
Vildagliptin—Pancreatitis—Prednisone—ankylosing spondylitis	0.00864	0.00864	CcSEcCtD
Vildagliptin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00808	0.00808	CcSEcCtD
Vildagliptin—Weight increased—Prednisone—ankylosing spondylitis	0.00802	0.00802	CcSEcCtD
Vildagliptin—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00787	0.00787	CcSEcCtD
Vildagliptin—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00776	0.00776	CcSEcCtD
Vildagliptin—Angioedema—Prednisolone—ankylosing spondylitis	0.00772	0.00772	CcSEcCtD
Vildagliptin—Angiopathy—Betamethasone—ankylosing spondylitis	0.00735	0.00735	CcSEcCtD
Vildagliptin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00735	0.00735	CcSEcCtD
Vildagliptin—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00722	0.00722	CcSEcCtD
Vildagliptin—Angioedema—Triamcinolone—ankylosing spondylitis	0.0071	0.0071	CcSEcCtD
Vildagliptin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00709	0.00709	CcSEcCtD
Vildagliptin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00693	0.00693	CcSEcCtD
Vildagliptin—Oedema—Prednisolone—ankylosing spondylitis	0.0069	0.0069	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00685	0.00685	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00667	0.00667	CcSEcCtD
Vildagliptin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.0066	0.0066	CcSEcCtD
Vildagliptin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00657	0.00657	CcSEcCtD
Vildagliptin—Infestation—Methotrexate—ankylosing spondylitis	0.00657	0.00657	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00656	0.00656	CcSEcCtD
Vildagliptin—Angioedema—Dexamethasone—ankylosing spondylitis	0.00645	0.00645	CcSEcCtD
Vildagliptin—Angioedema—Betamethasone—ankylosing spondylitis	0.00645	0.00645	CcSEcCtD
Vildagliptin—Angiopathy—Prednisone—ankylosing spondylitis	0.0064	0.0064	CcSEcCtD
Vildagliptin—Oedema—Triamcinolone—ankylosing spondylitis	0.00634	0.00634	CcSEcCtD
Vildagliptin—Infection—Triamcinolone—ankylosing spondylitis	0.0063	0.0063	CcSEcCtD
Vildagliptin—Infection—Methylprednisolone—ankylosing spondylitis	0.00629	0.00629	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00621	0.00621	CcSEcCtD
Vildagliptin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00621	0.00621	CcSEcCtD
Vildagliptin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00615	0.00615	CcSEcCtD
Vildagliptin—Malnutrition—Prednisone—ankylosing spondylitis	0.00614	0.00614	CcSEcCtD
Vildagliptin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00613	0.00613	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00612	0.00612	CcSEcCtD
Vildagliptin—Hepatitis—Methotrexate—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00578	0.00578	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00577	0.00577	CcSEcCtD
Vildagliptin—Oedema—Betamethasone—ankylosing spondylitis	0.00576	0.00576	CcSEcCtD
Vildagliptin—Oedema—Dexamethasone—ankylosing spondylitis	0.00576	0.00576	CcSEcCtD
Vildagliptin—Infection—Dexamethasone—ankylosing spondylitis	0.00572	0.00572	CcSEcCtD
Vildagliptin—Infection—Betamethasone—ankylosing spondylitis	0.00572	0.00572	CcSEcCtD
Vildagliptin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00565	0.00565	CcSEcCtD
Vildagliptin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00565	0.00565	CcSEcCtD
Vildagliptin—Angioedema—Prednisone—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Vildagliptin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00557	0.00557	CcSEcCtD
Vildagliptin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00557	0.00557	CcSEcCtD
Vildagliptin—Urticaria—Prednisolone—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Vildagliptin—Fatigue—Triamcinolone—ankylosing spondylitis	0.00547	0.00547	CcSEcCtD
Vildagliptin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00546	0.00546	CcSEcCtD
Vildagliptin—Angiopathy—Methotrexate—ankylosing spondylitis	0.00535	0.00535	CcSEcCtD
Vildagliptin—Chills—Methotrexate—ankylosing spondylitis	0.00529	0.00529	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00525	0.00525	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00525	0.00525	CcSEcCtD
Vildagliptin—Arthralgia—Prednisone—ankylosing spondylitis	0.00523	0.00523	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Vildagliptin—Malnutrition—Methotrexate—ankylosing spondylitis	0.00513	0.00513	CcSEcCtD
Vildagliptin—Urticaria—Triamcinolone—ankylosing spondylitis	0.00504	0.00504	CcSEcCtD
Vildagliptin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00503	0.00503	CcSEcCtD
Vildagliptin—Oedema—Prednisone—ankylosing spondylitis	0.00501	0.00501	CcSEcCtD
Vildagliptin—Infection—Prednisone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Vildagliptin—Fatigue—Dexamethasone—ankylosing spondylitis	0.00496	0.00496	CcSEcCtD
Vildagliptin—Fatigue—Betamethasone—ankylosing spondylitis	0.00496	0.00496	CcSEcCtD
Vildagliptin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Vildagliptin—Skin disorder—Prednisone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00485	0.00485	CcSEcCtD
Vildagliptin—Urticaria—Dexamethasone—ankylosing spondylitis	0.00457	0.00457	CcSEcCtD
Vildagliptin—Urticaria—Betamethasone—ankylosing spondylitis	0.00457	0.00457	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00457	0.00457	CcSEcCtD
Vildagliptin—Dizziness—Prednisolone—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Vildagliptin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00455	0.00455	CcSEcCtD
Vildagliptin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Vildagliptin—Arthralgia—Methotrexate—ankylosing spondylitis	0.00437	0.00437	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Vildagliptin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00433	0.00433	CcSEcCtD
Vildagliptin—Fatigue—Prednisone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Vildagliptin—Headache—Prednisolone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Vildagliptin—Constipation—Prednisone—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Vildagliptin—Dizziness—Triamcinolone—ankylosing spondylitis	0.0042	0.0042	CcSEcCtD
Vildagliptin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00419	0.00419	CcSEcCtD
Vildagliptin—Infection—Methotrexate—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Vildagliptin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Vildagliptin—Asthenia—Betamethasone—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Vildagliptin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Vildagliptin—Nausea—Prednisolone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Vildagliptin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00405	0.00405	CcSEcCtD
Vildagliptin—Urticaria—Prednisone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Vildagliptin—Headache—Triamcinolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Vildagliptin—Headache—Methylprednisolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Vildagliptin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Vildagliptin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Vildagliptin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00381	0.00381	CcSEcCtD
Vildagliptin—Dizziness—Betamethasone—ankylosing spondylitis	0.00381	0.00381	CcSEcCtD
Vildagliptin—Nausea—Triamcinolone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Vildagliptin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00362	0.00362	CcSEcCtD
Vildagliptin—Fatigue—Methotrexate—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Vildagliptin—Headache—Dexamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Vildagliptin—Headache—Betamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Vildagliptin—Asthenia—Prednisone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Vildagliptin—Diarrhoea—Prednisone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Vildagliptin—Nausea—Betamethasone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Vildagliptin—Nausea—Dexamethasone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Vildagliptin—Urticaria—Methotrexate—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Vildagliptin—Dizziness—Prednisone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Vildagliptin—Headache—Prednisone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Vildagliptin—Asthenia—Methotrexate—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Vildagliptin—Nausea—Prednisone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Vildagliptin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Vildagliptin—Dizziness—Methotrexate—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Vildagliptin—Headache—Methotrexate—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Vildagliptin—Nausea—Methotrexate—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
